Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI).
Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Lucentini L, Matteoli MC, Crinò A, Corbi S, Spera S, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Sulli N, Cervoni M, De Mattia G, Faldetta MR, Boscherini B, Pozzilli P, et al. Visalli N, et al. Among authors: matteoli mc. Diabetes Metab Res Rev. 1999 May-Jun;15(3):181-5. doi: 10.1002/(sici)1520-7560(199905/06)15:3<181::aid-dmrr31>3.0.co;2-h. Diabetes Metab Res Rev. 1999. PMID: 10441040 Clinical Trial.
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crinò A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MR. Pozzilli P, et al. Among authors: matteoli mc. Eur J Endocrinol. 1997 Sep;137(3):234-9. doi: 10.1530/eje.0.1370234. Eur J Endocrinol. 1997. PMID: 9330586 Clinical Trial.
No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G. Pozzilli P, et al. Among authors: matteoli mc. Diabetologia. 2000 Aug;43(8):1000-4. doi: 10.1007/s001250051482. Diabetologia. 2000. PMID: 10990077 Clinical Trial.
A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8).
Pozzilli P, Crinò A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G; IMDIAB Group. Pozzilli P, et al. Among authors: matteoli mc. Diabetes Technol Ther. 2003;5(6):965-74. doi: 10.1089/152091503322641006. Diabetes Technol Ther. 2003. PMID: 14709198 Clinical Trial.
A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
Crinò A, Schiaffini R, Manfrini S, Mesturino C, Visalli N, Beretta Anguissola G, Suraci C, Pitocco D, Spera S, Corbi S, Matteoli MC, Patera IP, Manca Bitti ML, Bizzarri C, Pozzilli P; IMDIAB group. Crinò A, et al. Among authors: matteoli mc. Eur J Endocrinol. 2004 May;150(5):719-24. doi: 10.1530/eje.0.1500719. Eur J Endocrinol. 2004. PMID: 15132730 Clinical Trial.
A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
Crinó A, Schiaffini R, Ciampalini P, Suraci MC, Manfrini S, Visalli N, Matteoli MC, Patera P, Buzzetti R, Guglielmi C, Spera S, Costanza F, Fioriti E, Pitocco D, Pozzilli P; IMDIAB Group. Crinó A, et al. Among authors: matteoli mc. J Pediatr Endocrinol Metab. 2005 Aug;18(8):749-54. doi: 10.1515/jpem.2005.18.8.749. J Pediatr Endocrinol Metab. 2005. PMID: 16200840 Clinical Trial.
The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).
Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola GB, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Pitocco D, et al. Among authors: matteoli mc. Diabet Med. 2006 Aug;23(8):920-3. doi: 10.1111/j.1464-5491.2006.01921.x. Diabet Med. 2006. PMID: 16911633 Clinical Trial.
Age at diagnosis of type 1 diabetes and the effect of immunomodulatory therapies on residual beta cell function.
Pitocco D, DiStasio E, Crinò A, Manfrini S, Guglielmi C, Visalli N, Suraci C, Matteoli MC, Cavallo MG, Bizzarri C, Pozzilli P; IMDIAB Group. Pitocco D, et al. Among authors: matteoli mc. Horm Metab Res. 2008 Jan;40(1):66-8. doi: 10.1055/s-2007-993217. Epub 2007 Dec 18. Horm Metab Res. 2008. PMID: 18085501 Clinical Trial. No abstract available.
30 results